Established in 2004, Akums Drugs and Pharmaceuticals Limited is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services.
Financial Results:
Akums Drugs & Pharmaceuticals Ltd reported Revenues for Q4FY25 of ₹1,056.00 Crores up from ₹944.00 Crore year on year, a rise of 11.86%.
Total Expenses for Q4FY25 of ₹1,007.00 Crores up from ₹987.00 Crores year on year, a rise of 2.03%.
Consolidated Net Profit of ₹150.00 Crores from -₹39.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹9.38, from -₹2.89 in the same quarter of the previous year.